NU-2058 [161058-83-9]
N800000
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameNU-2058 [161058-83-9]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- Scientific DescriptionCDK1/2 inhibitor.; NU2058, O6-Cyclohexylmethylguanine
- Storage Instruction4°C
- UNSPSC12352200
References
- Rigas, A., Robson, C., et al. Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer. Oncogene. 26(55): 7611-7619 (2007). PMID 17599054. Johnson N., Bentley J., et al. Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. Br J Cancer. 102(2):342-350 (2010). PMID: 20010939.